• Dept. of Medicine Grand Rounds

    Evaluation and Attendance
  • Which date did you attend Grand Rounds?*
     - -
    2 digit month, 2 digit day, 4 digit year

  • Ruth J. Napier, PhD

    Title: A Dual Role for Genetic Risk Factors in Infection and Autoimmunity

     learning Objectives:

    1. Gain a better understanding of how the environment can trigger autoimmunity.
    2. Understand the role of genetic mutations in predicting response to therapy in spondyloarthritis.
    3. Learn how basic research findings can be implemented in the clinic.






  • Jessica F. Hebert, PhD

    Title: Long-Term Effects of Rhabdomyolysis on Renal, Reproductive, and Developmental Health

     learning Objectives:

    1. Identify a key cause and the basic mechanism by which young people get AKI
    2. Discuss potential detection methods for pregnancy complications induced by previous AKI
    3. Plan ways to address previous AKI with current patients considering pregnancy






  • Jeffrey A. Gold, MD

    Title: Artificial Intelligence- The Architect or the Vision for Clinical Documentation?

     Learning Objectives:

    1. To describe ways in which Artificial Intelligence is being deployed to facilitate clinical documentation
    2. To describe the risks and pitfalls to using current Artificial Intelligence Models for documentation
    3. To describe to new uses for Artificial Intelligence to facilitate documentation beyond Ambulatory Care






  • Miranda Merrill, MD

    Title: Acute myocardial infarction and the modern CVICU

     Learning Objectives:

    1. Recognize the incidence, morbidity and mortality associated with acute myocardial infarction (AMI) and AMI complicated by cardiogenic shock
    2. Understand the progress that has been made in the treatment of AMI and become familiar with the most recent literature looking at improving outcomes in the AMI and AMI shock population
    3. Realize changes in the epidemiology of the CVICU patient population and CVICU staffing structure






  • Stuti Fernandes, MD

    Title: Primary Hyperaldosteronism

     Learning Objectives:

    1. Review the renin-angiotensin-aldosterone system
    2. Define primary hyperaldosteronism and differentiate it from essential HTN
    3. Improve screening for primary hyperaldosteronism 
    4. Diagnose primary hyperaldosteronism
    5. Learn about the role of adrenal vein sampling
    6. Treat primary hyperaldosteronism

     

  • David Lieberman, MD

    Title: Colorectal Cancer Screening: What is new in 2024?

     Learning Objectives:

    1. Review evidence for initiating colorectal cancer (CRC) screening at age 45
    2. Recognize the issues surrounding use of current CRC screening tests including:
         - Adherence
         - Quality
         - Barriers and equity issues 
    3. Interpret new data about Stool-based and blood-based screening tests

  • Devan Kansagara, MD

    Title: A hanhich, gungun, or bambalacha by any other name: Cannabis and your patients’ health

    Learning Objectives:

    Participants will be able to:
    1. Define basic terminology, formulations, routes of administration, and pharmacokinetics of cannabis
    2. Discuss the effectiveness of cannabis for chronic pain and other conditions
    3. Identify harm reduction strategies for patients using cannabis for medical or recreational purposes

  • Trisha Wong, MD, MS

    Title: Pediatric to Adult Transition Healthcare (PATH)

    Learning Objectives:

    1. Review the who/why/what of high-quality peds-to adult transition for generalists and subspecialists
    2. Using cases, learn what various pediatric programs are doing to prepare our young adults for transition
    3. Discuss current gaps and next steps to optimize peds-to-adult transition enterprise-wide

  • James Clements, MD, FACP & Matthias Merkel, MD

    OHSU Mission Control/Transfer Center: Fulfilling Our Promise for Oregon

    Learning Objectives:

    1. Understand the basics of OHSU Mission Control
    2. Connect the mission of helping people with capacity and throughput
    3. Know how they can be a part of the changes as we grow together

  • Julia Tasset, MD

    Birth Control Bootcamp: Conquering Contraception at Every Level!

    Learning Objectives:

    1. Identify indications and best practices for contraception counseling and review currently available contraceptive technologies in the United States
    2. Utilize the CDC Medical Eligibility Criteria to support patient-specific counseling and risk stratification
    3. Explore limits of contraceptive safety and efficacy knowledge for people living with renal disease and refer to Complex Family Planning for counseling and management

  • Kristina Bajema, MD, MSc; Ellie Sukerman, MD; James Lewis, MD

    Oral Antibiotics for Bloodstream Infections: Not All Orals Are Created Equal

    Learning Objectives:

    1. Understand the general advantages of oral over intravenous antibiotic therapy for bloodstream infections.
    2. Understand the appropriate selection and dosing of oral antibiotics for common gram-negative bloodstream infections.
    3. Understand the appropriate selection and dosing of oral antibiotics for common gram-positive bloodstream infections.

  • Eric Ryan, MD & Scott Naugler, MD

    Terlipressin therapy for Hepatorenal Syndrome: Evidence, Indications, and Implementation

    Learning Objectives:

    1. Understand the broad mechanism and implications of hepatorenal syndrome.
    2. Review the evidence for treatment of hepatorenal syndrome, including the recent FDA approval of terlipressin.
    3. Understand the risks of treatment with terlipressin.
    4. Gain familiarity with the usage of terlipressin at OHSU.

  • Donald Sullivan, MD

    Do you hear what I hear? Fostering Effective Patient-Clinical Communication

    Learning Objectives:

    1. Describe the evolution of patient-clinician communication
    2. Define shared decision-making and Learn ways to implement shared decision-making best practices in clinical care
    3. Review the role of decision aids in fostering shared decision-making
    4. iDECIDE study (Improving Decision Making in Lung Cancer)

  • David Dorr, MD, MS, FACMI, FAMIA, FIAHSI

    Building an Artificial Intelligence (AI)- Enabled Learning Health System (LHS) at OHSU

    Learning Objectives:

    1. Describe the function and purpose of a Learning Health System.
    2. Understand the definition of ‘Artificial Intelligence’, current evidence for its use, and high level issues around implementation, risk and benefit of AI.
    3. Identify the opportunities for an AI-enabled Learning Health System at OHSU, especially as it evolves into a larger public university system.
    4. Develop your own ideas for health care innovations that may be facilitated by an AI-enabled Learning Health System.

  • Robert M. Wilechansky, MD

    What’s New in MASLD: Nomenclature, Risk Stratification, and Therapeutics

    Learning Objectives:

    1. Define MASLD and the steatotic liver disease spectrum using updated nomenclature and diagnostic criteria
    2. Determine when to refer a patient with MASLD to a GI/hepatology specialist
    3. Discuss the novel therapeutic drug classes for MASLD and the available clinical trial data

  • Michael LaMantia, MD, MPH, AGSF, FACP

    Changing Tides in Alzheimer’s Disease: Diagnosis, Treatment, and Palliation

    Learning Objectives:

    1. To discuss the on-going evolution of criteria for diagnosis with Alzheimer’s Disease
    2. To describe developments in therapeutic agents for Alzheimer’s Disease
    3. To discuss changes in the use of medical aid in dying to avoid late-stage dementia

  • Sydney Ey, PhD; Megan Furnari, MD, MS; Abigail Lenhart, MD, FACP

    (Re)Locating Yourself in Healthcare: What now and What next? A well-being case study

    Learning Objectives:

    1. Summarize current trends and statistics on burnout in the healthcare workforce
    2. Learn about evidence-based strategies improve wellbeing in healthcare
    3. Review what resources are available at OHSU

  • Giulia Leggett, MD & Noriyuki Murakami, MD

    Immigrant Health: Review of Asylum Medicine

    Learning Objectives:

    1. Define difference between refugee and asylee
    2. Identify parts of asylum evaluation for medical-legal affidavits
    3. Review local trends of asylum cases for Oregon

  • Sujeet Govindan, MD

    Myths and Misconceptions In Infectious Disease

    Learning Objectives:

    1. Discuss the evidence for the use of oral vs IV antibiotics in bone and joint infections
    2. Review the evidence and potential harms on the use of anti-anaerobic antibiotics in aspiration pneumonia
    3. Understand where antibiotic susceptibilities may be misleading in treatment of AmpC enzyme producing infections
    4. Discuss the lack of utility of fungal blood cultures
    5. Review the data on linezolid and serotonin syndrome

  • Nayan Arora, MD, FASN

    Cardiorenal Syndrome and the Art of Decongestion

    Learning Objectives:

    1. Understand the rationale for incomplete decongestion in patients with ADHF
    2. Describe the mechanisms involved in diuretic resistance
    3. Understand the role hypochloremia plays in the pathogenesis of heart failure

  • Luiza Caramori, MD

    Management of Diabetes in CKD: Reducing Cardio-Renal Risk

    Learning Objectives:

    1. After participating in this session, attendees should be able to understand and apply appropriate screening methods to diagnose chronic kidney disease in patients with diabetes
    2. After participating in this session, attendees should be able to integrate current medical knowledge in selecting suitable medications with kidney- and heart-protective properties
    3. After participating in this session, attendees should be able to understand the role of a multidisciplinary team including dietitians and diabetes educators in managing chronic kidney disease in patients with diabetes

  • Jared Chiarchiaro, MD MS; Briana Ketterer, MD, MS, FACP; Katie H. Stowers, DO

    Goals of Care in Sepsis: A Call for Transformational Change

    Learning Objectives:

    1. To discuss the importance of goals of care for patients with sepsis, the current OHSU standard of care and ongoing work
    2. To understand how implementation of goals of care in sepsis is a transformational change in our health care system
    3. To propose education initiatives as the foundation for this system-level change

  • Kylee Martens, MD

    Unraveling Bias: Lab-Based Inequities in Hematology

    Learning Objectives:

    1. Identify inequities in hematological reference ranges
    2. Recognize populations likely to be affected by structural inequity in hematology
    3. Examine the impact of lab-based inequities on the normalization of disease states and delayed diagnoses

  • Honora Englander, MD

    Rethinking addiction care: Lessons from France for the US

    Learning Objectives:

    1. Describe the historical context of opioid use disorder (OUD) care in the United States and how that context continues to impact US addiction care today.
    2. Compare US and French approaches to opioid use disorder (OUD) care, including sharing findings from a study of interprofessional healthcare clinicians in France.
    3. Discuss potential implications for addiction care at OHSU and elsewhere.

  • Rodica Busui, MD, PhD

    Heart Failure in Diabetes: From Guidelines to Clinical Care Implementation

    Learning Objectives:

    1. Provide a brief epidemiology overview of heart failure in diabetes and context
    2. Review potential mechanisms, diagnosis and staging
    3. Discuss current guidelines for managing people with diabetes and heart failure and steps for guidelines implementation at the point of care

  • Saket Sanghai, MBBS, FACC, FHRS

    Contemporary Management of Atrial Fibrillation - What’s new in the guidelines

    Learning Objectives:

    1. Discuss contemporary, comprehensive management of atrial fibrillation
    2. Discuss the new 2023 atrial fibrillation guidelines
    3. Discuss future directions in atrial fibrillation related care

  • Elly Karamooz, MD

    Is a new TB vaccine in our future?

    Learning Objectives:

    1. Why is a new TB vaccine needed?

    2. What are the challenges in developing a new TB vaccine?

    3. Why is M72/AS01E a promising vaccine candidate?

  • Nupur S Mistry, MD

    Resistant Hypertension and Novel Antihypertensive Therapies

    Learning Objectives:

    1. Define resistant hypertension

    2. Discuss the need for novel anti-hypertensive therapies

    3. Review mechanism of novel anti-hypertensive agents that are under development

  • Joaquin Cigarroa, MD

    The Evolving Ecosystem of Innovation

    Learning Objectives:

    1. 1. Develop an understanding of funding sources for research

      2. Understand how FDA initiatives on medical devices have accelerated innovation of cardiovascular devices

      3. Identify current threats which have the potential to diminish innovation and patient care

  • Robert M. Arnold MD

    Family Conflict: Going from “They Are Just Unrealistic” to Shared Decisions

    Learning Objectives:

    1. What are three reasons why seriously ill families/patients ask for things that you think are unreasonable?
    2. What is a headline?
    3. What are the best questions to ask a surrogate to learn about an incapacitated patient’s values?

  • Carlos Estrada, MD, MS

    The Art of Saying Yes: Maximize Professional Advancement while Maintaining Your Sanity!

    Learning Objectives:

    1. List 3 benefits for saying YES to clinical, educational, administrative, or research opportunities.
    2. List 3 drawbacks to saying NO to new opportunities.
    3. Identify opportunities for personal or professional advancement.

  • Siddharth Javia, MD

    Role of endoscopy in esophageal & gastroesophageal junction cancers

    Learning Objectives:

    1. Early cancer detection: whom to screen?
    2. Role of endoscopy in diagnosis, staging and treatment
    3. T1a intramucosal cancer vs T1b submucosal cancer management

  • Steven E. Mansoor, M.D., Ph.D.

    From Molecular Structure to Drug Development

    Learning Objectives:


    1. Structural biology is the study of the three-dimensional (3D) structure of biological molecules such as proteins. The 3D structure of these molecules generally defines their function. The “structure-function” paradigm is at the heart of biochemistry and can be used to leverage the design of novel small-molecule drugs through “structure-based drug design”. Cryo-electron microscopy (Cryo-EM) is a prominent technique in the field of structural biology to get high-resolution structures of receptors and proteins. We have a national center on the OHSU campus called the Pacific Northwest Center for Cryo-EM (PNCC) where cutting-edge microscopy takes place.

    2. P2X receptors are ion channels that sense extracellular ATP, which is a “danger signal” to cells. There are seven different P2X receptor subtypes (designated P2X1-P2X7) which play important roles in the central nervous system, the cardiovascular system, and the immune system. The development of subtype-selective small molecules will be key to modulating the function of these ion channels.

    3. The P2X7 receptor subtype is expressed in cells of the immune system (including microglia) and its activation propagates the signaling of acute and chronic inflammation. In the central nervous system, P2X7 receptor activity is implicated in Alzheimer's disease pathology, including neuroinflammation, amyloid plaque formation, and cognitive decline. In the cardiovascular system, P2X7 deficiency resolved plaque inflammation and reduced experimental atherosclerosis. The development of P2X7 receptor antagonists can potentially be used as therapy to treat conditions such as neurodegeneration and vascular inflammation.

  • Joel R. Burnett, MD, FACP, Kathleen F. Carlson, MS, PhD, Katie Iossi, MD, MPH, FACP, Kelsi Manley, MD, FACP

    It's in Our Lane: A Public Health Approach to Firearm Injury Prevention for Health Professionals

    Learning Objectives:

    1. Discuss firearm injury epidemiology in Oregon
    2. Describe a public health perspective on firearm injury prevention using the social-ecological model, including clinicians' roles and the policy environment
    3. Describe an approach to talking about firearms with patients, including the four principles of secure storage and extreme risk protection orders
    4. Identify ongoing and needed research in the public health approach to firearm injury prevention

  • Stefan Barisic, MD Resident Physician PGY-2, Internal Medicine
    Alex Belzer, MD PGY-1 Internal Medicine
    Makrina Kamel, DO Department of Medicine, PGY1
    Hannah King, DO Internal Medicine, PGY-3
    Vishvaas Ravikumar, MD

    Year in Review: A Selection of Resident Scholarly Work

    Learning Objectives:

    1. Understand the potential of human endogenous retroviruses (HERVs) as a novel source of targetable antigens in cancer cell therapy
    2. Understand IgG4-related disease
    3. Characterize the clinical manifestations and treatment of babesiosis
    4. Describe patient outcomes related to the use of electronic consultation for iron deficiency and consider ways to improve the EHR
    5. Review risk stratification in AML and venetoclax-based regimens

  • Jessica L. Mellinger, MD MSc.

    Integrated Care for ALD: Current Practice and New Horizons

    Learning Objectives:

    1. To identify importance of integrated care for patients with alcohol-related liver disease
    2. To identify strategies for integrated care at different levels
    3. To understand the association of integrated care for ALD patients with improved clinical outcomes

  • Congresswoman Maxine Dexter, MD, and  Sarah York, MD

    Physician Leadership: A Prescription for a Sick Democracy

    Learning Objectives:

    1. Learn about impacts of recent proposed federal legislation on Medicaid, PBMs, etc.
    2. Discuss impacts of Executive Orders, including those addressing Equity initiatives and NIH funding
    3. Understand the impact of clinician voice and leadership, and consider opportunities for physician advocacy locally and nationally

  • Jina Makadia, MD

    OPAT – Infection Management Beyond Hospital Walls

    Learning Objectives:

         1. Describe OPAT at OHSU - history and current team
         2. Understand the OPAT processes at OHSU
         3. Review Dalbavancin data for complicated infections & it's use at OHSU

  • Chaim Vanek, MD

    Fibrodysplasia Ossificans Progressiva and Uma Thurman

    Learning Objectives:

         1. Differential Diagnoses of Ectopic Calcification and Ossification
         2. Presentation and Pathophysiology of Fibrodysplasia Ossificans Progressiva
         3. Treatment of Fibrodysplasia Ossificans Progressiva

  • Rana L. A. Awdish, MD MS FACP FCCP

    Healing with Intention

    Learning Objectives:

    1. Describe the tension between the demands of medical training and our desire to practice compassion.
    2. Illustrate how considering and defining our purpose can provide a foundation in difficult moments.
    3. Recognize the barriers to implementing institutional change and empowering individuals.
    4. Identify practices that will engage providers and leaders in promoting development of resilient systems.

  • Esther Chong, MD

    Cancer Is Getting Younger: The Alarming Rise in Early-Onset Cases

    Learning Objectives:

    1. Growing trends of early onset cancer
    2. Various lifestyle factors contribute to these trends
    3. Guidelines for earlier cancer screenings

  • Brian P. Davidson, MD

    Better with Bubbles: Ultrasound Enhancing Agents (UEAs) in Medicine

    Learning Objectives:

    1. Understand the composition and safety profile of Ultrasound Enhancing Agents (UEAs)
    2. Review the current clinical applications for UEAs and evidence support their use
    3. Introduce emerging diagnostic and therapeutic applications for UEAs across medicine

  • Mohamad Bittar, MD, MS

    Pain Mechanisms in Spondyloarthritis

    Learning Objectives:

    1. Review pain phenotypes in Spondyloarthritis
    2. Review the approach to individualized treatment

  • Erynn Beeson, MD Ryan Friedman, MD Shira Peress, MD Hannah Zane, MD PhD

    Leading through Change: Lessons from Chief Year

    Learning Objectives:

    1. Describe key models of change management and discuss their application to leadership challenges in medical education.
    2. Examine the personal and professional impact of real-world events (e.g., political transitions, program changes, personal crises) on medical trainees.
    3. Reflect on leadership lessons gained through navigating crises and transitions during chief residency.

  • R. Logan Jones, MD

     

    Bots, Bias, and Breakthroughs: AI Across the Missions of Medicine

    Learning Objectives:

    1. Describe what artificial intelligence (AI) is, how it functions, and its current limitations.
    2. Identify appropriate AI tools and articulate their strengths and optimal use cases.
    3. Illustrate practical applications of AI across the core pillars of academic medicine(clinical care, education, research, and administration).
    4. Evaluate potential risks and ethical considerations associated with integrating AI into professional practice.

  • Mary Brooks, MD, and Elizabeth Eckstrom, MD, MPH

     

    “Age-Friendly Transitions of Care for Older Adults”

    Learning Objectives:

    1. Understand the new CMS mandated Age-Friendly Hospital Measures

    2. Discuss the dilemmas facing older adult patients, providers, and hospital systems surrounding discharge transitions of care

    3. Review current efforts at OHSU to improve discharge transitions of care in alignment with the new CMS Age-Friendly Hospital Measures

       

       

  • Terri Hough, MD, MSc

     

    What's new? What's great? Kicking off the new academic year for the OHSU Department of Medicine

    Learning Objectives: 

  • Nilan Schnure, MD and Aaron Silver, MD

     

    Punch your ticket on the POCUS steam train

    Learning Objectives: 

    1. Articulate basic interpretation and role of lung ultrasound

    2. Apply the I-AIM framework to thoughtfully support trainee POCUS use

    3. Discuss how POCUS fits into current and future clinical care and        trainee education

       

  • Nathan D. Nielsen, M.D., M.Sc

     

    Don't Buy ACME!: Lessons in Sepsis Trial Design from Wile E Coyote

     

    Learning Objectives: 

    1. To appreciate the limitations of an over-simplified, syndromic framing of "sepsis"

    2. To discover several novel approaches being implemented in septic shock trial design

    3. To be dissuaded from buying ACME products in the future (i.e.: "magic bullet" therapies)

  • Julie Doberne, M.D., Ph.D.

     

    The Surgical Data and Decision Sciences Lab

     

    Learning Objectives: 

    1. Explain the mission and scope of the SDDSL

    2. Describe key research approaches and innovations used by the SDDSL

    3. Explain why these research approaches inform surgeon and patient decision making

       

  • Ilya Ivlev, MD, PhD, MBI 

    Annette M. Totten, PhD, MPA

     

    Creating Navigations Aid for Clinical Practice and Policy: The Past and (hopefully) Future of The Pacific Northwest Evidence-Based Practice Center.

     

    Learning Objectives: 

    1. Understand the scope of evidence-based medicine and the specific roles of systematic reviews, practice guidelines, and protocols in quality of care and patient safety.

    2. Identify how evidence has impacted your practice or field.

    3. Assess how key changes in policy and technology may impact evidence-based practice.

       

  • Nathaniel Hocker, MD 

    Nephrology - A Year in Review

    Learning Objectives: 

    1. Utilize 2024 KDIGO CKD Guidelines in clinical practice

    2. Identify which patients will benefit from renal protection offered by GLP1 receptor agonists and SGLT2 inhibitors

    3. Optimize blood pressure control to maximize renal and cardiovascular benefit in accordance with recent data

    4. Integrate awareness of new and emerging treatment options for glomerulonephritis

    5. Increase sodium levels safely and efficiently to minimize poor outcomes

  • Kelly Caverzagie, MD 

    Great People. Great Things: OHSU & The Education Mission

    Learning Objectives: 

    1. Reflect upon the amazing people who are doing great things at OHSU

    2. Identify key priorities for the SOM as it relates to the educational mission

    3. Recognize how to positively contribute to the education mission

       

  • Stephanie Egge, MD

    A Crash Course in Gram-negative Antimicrobial Resistance

    Learning Objectives: 

    1. Identify key clinical Gram-negative bacterial pathogens and their emerging antimicrobial resistance risk

    2. Identify novel antimicrobials that equip us to anticipate and fight frequently encountered antimicrobial resistant Gram-negative infections

    3. Recognize clinical scenarios that require novel antimicrobial escalation and ID consult guidance for above standard antimicrobial therapies
      ion

       

  • Drs Alex Belzer, Madeleine Gertz, Sean Kim, Peter Liu, Ben Nichols, Hunter Owen, Andrea Smeraglio, and Sydney Villa

    Teaching Improvement Science (TIS): Projects from a Health Systems Science Curriculum

     

    Learning Objectives: 

    1. Appreciate what residents are learning about Health Systems Science

    2 . Recognize the improvement work residents are doing at OHSU and the Portland VA.

    3.  Identify opportunities to get involved in education and Health Systems Science.

     

  • Winnie Liu, MD, CCD

    Osteogenesis Imperfecta in Adults

     

    Learning Objectives: 

    1.  Overview of our current understanding of osteogenesis imperfecta genotypes and phenotypes.

    2. Review of our research data on fractures rates and anti-fracture medication use in adults with osteogenesis imperfecta.

    3. Outline of gaps in knowledge in our current care of adults with osteogenesis imperfecta.

     

     

  • Nathalie Javidi-Sharifi, MD, PhD

    Chronic Lymphocytic Leukemia in 2025: Lessons from the Past, Current Standards, and What’s Next

    Learning Objectives: 

    1.  Review the evolution of CLL treatment from chemoimmunotherapy to targeted agents (BTK and BCL2 inhibitors).

    2.  Apply practical principles for therapy selection and co-management of toxicities relevant to internal medicine.

    3.  Recognize emerging therapies (non-covalent BTKi, time-limited combinations, bispecific antibodies) and when to consider referral for clinical trials.

  • Rand Ladkany, MD and Bailey Pope, MD

     

    Feedback that Fuels Learning: Practical Tools for Educators

    Learning Objectives: 

    1. Describe the three parts of the educational alliance

    2. Describe the key elements required to set the stage for effective feedback

    3. Apply the prepare to ADAPT and DESC frameworks to deliver effective feedback

    4. Identify common challenging feedback scenarios, and discuss strategies to approach them

     

  • Todd Korthuis, MD, Linda Peng, MD, Hunter C. Spencer, DO, AAHIVS, 

    Rolin Block PRIME + PEER, CRM, PSS, PWS

     

    The Oregon Model: Peer-based interventions for rural people who use drugs – healthcare re-imagined

    Learning Objectives: 

    1. To understand the role of peers in engaging rural communities in treatment, with example from people who use drugs

    2. To learn about peer intervention outcomes for decreasing overdose and improving treatment engagement for substance use, hepatitis C, and heart disease.

    3. To understand the interplay between state, community, and academic medical center resources in rapidly translating research into practice

       

     

  • Rebecca Harrison MD, and Christopher Slatore, MD

     

    DOM Award Presentations - Stories of Purpose and Meaning

    Learning Objectives: 

    1. celebrate purpose and excellence

    2. inspiration from colleagues who lead with meaning

    3. connect with our values

       

     

  • Jennifer L. LeTourneau, DO, MCR, FACP, FCCM

     

    Leadership is Action, Not Position: Tips for Leading Now

     

    Learning Objectives: 

    1. Distinguish between positional authority and behavioral leadership

      Participants will be able to identify the key differences between formal leadership roles and leadership actions, understanding that influence and impact can come from any level within an organization.

    2. Apply practical leadership behaviors in current roles

      Participants will learn specific, actionable strategies they can implement immediately to demonstrate leadership qualities, regardless of their job title or hierarchical position.

    3. Develop skills for leading without formal authority

      Participants will gain techniques for building influence, motivating others, and driving positive change through collaboration, communication, and example-setting rather than relying on organizational power structures.

    4. Create personal action plans for immediate leadership implementation

      Participants will identify specific opportunities within their current work environment to practice leadership behaviors and develop concrete steps for becoming more effective leaders.

       

       

     

  • Hind Rahmouni, MD

     

    The Hidden Killer: Lipoprotein(a)

    From Unknown Risk to Treatable Target

     

    Learning Objectives: 

    1. Explain the unique molecular structure of Lp(a) and how genetic variability is associated with increased cardiovascular risk.

    2.  Identify appropriate candidates for Lp(a) screening to guide clinical decision-making.

    3. Discuss emerging RNA-based therapies that achieve significant Lp(a) reduction and their potential to transform cardiovascular disease prevention. 

  • Ayako Mayo, MD and Mengyu Zhou, MD, FACP

    Updates in Hospital Medicine

    Learning Objectives: 

    1. Suggest five adjustments in medication use for hospitalized patients justified by new evidence

    2. Identify three decisions with interventions in hospitalized patients where new evidence may change practice

    3. Recognize one strategy to support early recognition of morbidity in hospitalized patients based on new evidence

  • Nathan R. Selden, M.D., Ph.D., FACS, FAAP.

    Where did the concept professionalism come from and is that a problem?

    Learning Objectives: 

    1. Identify core features of professionalism that have stood the test of time.

    2. List misuses and misrepresentations of “professionalism” that hinder outcomes past and present.

    3. Describe approaches to advance the humanity of medicine within the modern context through re-embracing and re-defining professionalism for our times.

  • Bruce A. Perkins,  MD MPH

    The Changing Paradigms of Type 1 Diabetes Care and Research

    Learning Objectives: 

    1. Describe newly recognized T1D-associated morbidities

    2. Explain Hybrid Closed Loop in practice and the research to improve its glycemic outcomes

    3. Discuss new innovations including immune therapies for pre-clinical T1D and the role of cell-based therapies in clinical care

  • Anand Kumthekar, MD, RhMSUS and Lynne Strasfeld, MD 

    GRANDMED- Grand Rounds Academic Network Database in Medicine
    Promotion & tenure - overview and updates

    Learning Objectives: 

    1. Understand utility of GRANMED

    2. Understand how to leverage GRANDMED to build external reputation for faculty members

    3. Understand the rubric/process for promotion evaluation at OHSU, including how that system has and continues to evolve over time

    4. Know how to locate and leverage the resources available to OHSU DOM faculty to assist in the P&T process

  • Joshua Curry, MD

    Dietary Potassium Stress and the Kidney: Transport, Remodeling, and Injury

    Learning Objectives: 

    1. Understand how hypokalemia alters kidney transport of sodium and impacts blood pressure regulation

    2. Evaluate how dietary potassium intake influences kidney and cardiovascular health, at both the population level and mechanistically

    3. Understand how emerging genetic and spatial transcriptomic approaches may clarify cell-specific potassium sensing and pro-inflammatory pathways

       

  • Cong-Qiu Chu, MD

    Biological DMARDs

    Learning Objectives: 

    1. Describe the immunopathogenesis of inflammatory rheumatic diseases and identify pathways targeted by biological DMARDs with a focus on TNF, IL-6, IL-17, IL-1, B cells, T-cell co-stimulation.

    2. Explain the mechanism of action, indications, and clinical efficacy of major classes of biological DMARDs such as TNF inhibitors, IL-6 inhibitors, IL-17/23 inhibitors, IL-1 inhibitors, anti-CD20 therapy, CTLA-4-Ig.

    3. Compare the safety profiles and monitoring requirements for biological DMARDs, including risks of infections, malignancy, and organ-specific toxicities.

    4. Recognize and manage adverse events and special clinical situations, including vaccine recommendations, perioperative management, pregnancy, and latent TB screening.

    5. Discuss emerging biologics and biosimilars, including their role in improving access, cost considerations, and therapeutic strategies.

  • Jenna Anderson, MD, Kaleb Keyserling, MD and Gabriel Monti, MD

    Improving Colorectal Cancer Screening for Veterans through an Organized Mailed Fecal Immunochemical Test (FIT) Program

    Learning Objectives: 

    1. Understand colorectal cancer screening guidelines

    2. Recognize components of successful colorectal cancer screening programs

    3. Describe the VA Portland Healthcare Center’s Mailed Fecal Immunochemical Test (FIT) Program

  • Ted Braun, M.D., Ph.D., Todd Korthuis, MD, MPH, Katie Lebold, MD PhD, and Patrick G Lyons, MD, MSc

    Celebrating Excellence in Department of Medicine Research

    Learning Objectives: 

    1. Review Department of Medicine’s 2025 research accomplishments.

    2. Understand pathways to research for internal medicine residents.

    3. Learn about clinical deterioration from sepsis across the continuum of emergency and hospital care.

    4. Review the role of national collaboration to advance care for sepsis as an example of faculty research excellence.

  • Lisa Rotenstein, MD, MBA

    The Work of the Modern Physician: The Current Landscape and Solutions on the Horizon

    Learning Objectives: 

    1. Identify trends in physicians’ work intentions and workforce participation

    2. Describe methods for quantifying physician work

    3. Assess how novel technologies and organizational structures can enhance physicians’ work

       

  • Emerson Chen, M.D.

    GI Cancers Updates “Up, down, run around”

    Learning Objectives: 

    1. Perioperative chemotherapy with immunotherapy improves survival outcomes in resectable stage II & III gastro-esophageal (GE) adenocarcinoma compared to chemotherapy alone and compared to preoperative chemo-radiation.

    2. Neoadjuvant immune checkpoint inhibitors can induce high complete responses in stage II-III dMMR/MSI-high colorectal cancers to warrant successful surgery outcomes and nonoperative approaches.

    3. Exercise program can decrease cancer recurrence and improve survival outcomes in patients with resected colon cancer. 

  •  Peter Lee, MD

    What is Interventional Pulmonology?

    Learning Objectives: 

    1. History of Interventional Pulmonology as a subspecialty

    2. Awareness of the procedures and services provided by Interventional Pulmonology

    3. Awareness of the support staff and faculty behind Interventional Pulmonology at OHSU

  • Benjamin Lebwohl, MD, MS

    Treating Celiac Disease, Now and in the Future

    Learning Objectives: 

    1. Apply evidence-based strategies for the diagnosis of celiac disease, including appropriate use of serologic testing, genetic testing, and duodenal biopsy, and recognize common causes of missed or delayed diagnosis.

    2. Describe best practices for the management and long-term monitoring of celiac disease, including implementation of a gluten-free diet, assessment of mucosal healing, and appreciation of psychosocial challenges.

    3. Evaluate emerging and investigational therapies for celiac disease, including non-dietary treatments, biomarkers of gluten exposure, and current clinical trial designs aimed at improving patient outcomes beyond the gluten-free diet.

  • Richard A. Lange, MD, MBA

    Medicine and (Im)Migration in El Paso: Past and Present

    Learning Objectives: 

    1. List how El Paso has been at the forefront of medicine and migration

    2. Review unique aspects of border health that influence medical education and care

    3. Describe the healthcare implications of border policy

  • Megha Garg, MD, MPH and Anne Smeraglio, MD

    Guardianship for Patients without Capacity: Current Practices and Opportunities for Change

    Learning Objectives: 

    1. Demonstrate the impact of guardianship policies on inpatient and outpatient practices

    2. Discuss Veterans Affairs hospital data on patient outcomes and implications for practice

    3. Propose practice and policy changes to improve guardianship experiences for patients and providers

  • Morgan Hakki, MD

    Update on C. Difficile infection

    Learning Objectives: 

    1. Understand advances in our knowledge of the pathogenesis, changing epidemiology, and diagnosis of CDI

    2. Understand the basis for the recommended antibiotic treatment for first CDI episode and antibiotic options for recurrent infection

    3. Understand the changing landscape of microbiota-based products in the management of CDI

  • James Woodruff, MD

    The Anatomy of Reason: Supporting critical thinking & flourishing in medicine through the humanities

    Learning Objectives: 

    1. Understand the importance of critical thinking in rigorous practice and well-being

    2. Appreciate the connection between critical thinking and the humanities

    3. Be better prepared to pursue critical thinking in medical practice and education venues

  • Jonathan Q. Purnell, MD,  Rivfka Shenoy, MD, MS, and  Selvi Williams, MD, MPH 

    Current State of Obesity Management

    Learning Objectives: 

    1. Summarize the latest clinical trial data and guideline recommendations supporting lifestyle, pharmacologic, and surgical treatments for obesity.

    2. Analyze patient-specific factors to guide selection and outcome expectations of lifestyle treatments, anti-obesity medications and referral for metabolic/bariatric surgery.

    3. Implement patient-centered, stigma-reducing communication strategies that address weight bias, promote shared decision-making, and improve therapeutic alliance in the management of obesity.

  • Lee A. Lindquist, MD MPH MBA CMD FACP AGSF

    Mom and Dad need help! Deciding about Long Term Support

    Learning Objectives: 

    1. Identify issues that lead to older adults needing long term support services

    2. Determine strategies that can help older adults accept LTSS

    3. Discuss resources that can help older adults plan for LTSS in real-world health care settings

  • Wooin Ahn, MD, Ph.D

    Updates in Glomerular Diseases

    Learning Objectives: 

    1.  Outline the value of evaluating proteinuria and hematuria.

    2. Understand the implications of identifying target antigens in membranous nephropathy.

    3. Review the mechanisms of action and potential side effects of new medications for glomerular diseases

  • Anirudh Chintalapani, MD,  David A. Dorr, MD, MS, and Jeffrey A. Gold, MD

    Bringing AI to the Frontlines: Evaluating and Deploying AI at OHSU

    Learning Objectives: 

    1. Analyze strategic considerations that guide the selection and deployment of AI tools in clinical workflows.

    2. Evaluate the clinical purpose and strategic alignment of existing and emerging AI tools at OHSU.

    3. Apply principles of robust evaluation design to assess AI tools using A/B testing, comparative trials, and pilot implementations.

  • Firas Zahr, MD

    A Journey in Transcatheter Heart Valves

    Learning Objectives: 

    1. Basic understanding of valvular heart disease

    2. Approach of modern management of valvular heart disease

    3. Current technology and future directions of transcatheter heart valves

  • Nancy Spector, MD

    Reimagining Leadership in Academic Medicine in Times of Uncertainty

    Learning Objectives: 

    1. Describe current challenges and trends affecting the clinical and academic healthcare workforce

    2. Identify key factors to optimize career success

    3. Apply strategies for career planning and leadership development across different stages of an academic medical career

  • Curtis Lachowiez, MD

    Acute Myeloid Leukemia Management for Older adults in 2026: One Size does not fit all

    Learning Objectives: 

    1. Recognize that AML is a disease composed of many subtypes dependent on underlying genetics.

    2. Identify the standard of care treatment approach for older adults with AML.

    3. Understand how underlying genetics and treatment shape survival prognostication in patients with AML.

  • Jada Bussey-Jones, MD, MACP

    Primary Care’s Promise: Advancing Quality & Equity in a Changing System

    Learning Objectives: 

    1. Describe the clinical, population health, and health system benefits of strong primary care

    2. Identify current risks and workforce challenges facing primary care.

    3. Discuss evidence informed strategies to strengthen and reinvigorate the primary care workforce

  • Gurpreet Dhaliwal, MD

    The Last Mile of Medicine: Managing Uncertainty

    Learning Objectives: 

    1. Differentiate epistemic and aleatoric uncertainty

    2. Describe teaching strategies to help learners work productively with clinical uncertainty

    3. Explain why advances in technology — including AI — never eliminate uncertaintey

  • James Kornfield, MD

    Mucin' Up The Airways

    Learning Objectives: 

    1. Identify the underlying pathophysiologic mechanisms of asthma that has led to new targeted therapies and a change in the approach to asthma management.

    2. Described the emerging significance of mucus plugging in asthma and disease models.

    3. Evaluate the role of the airway mucin Muc5ac in host defense against respiratory viruses and its contribution to airway hyperresponsiveness.

     

    Ingrid Lindquist, MD

    Sarcoidosis in the Omics Era: Clinical Patterns, Molecular Signals, and Therapeutic Opportunities

    Learning Objectives: 

    1. Identify the underlying pathophysiologic mechanisms of asthma that has led to new targeted therapies and a change in the approach to asthma management.
    2. Described the emerging significance of mucus plugging in asthma and disease models.
    3. Evaluate the role of the airway mucin Muc5ac in host defense against respiratory viruses and its contribution to airway hyperresponsiveness.


     

  • Anne Smeraglio, MD

    Teaching Improvement Science:  Resident-Lead QI Projects 

    Learning Objectives: 

    1. Understand the Health Systems Science curriculum being delivered to trainees in the Department of Medicine.

    2. Recognize the key areas of resident-driven improvement projects at OHSU and the Portland VA.

    3. Identify two resident improvement projects currently underway.

  • Kara E. Walter, MD

    An update on the diagnosis and management of portal hypertension

    Learning Objectives: 

    1. Gain familiarity with the use of non-invasive testing for the identification of portal hypertension

    2. Review indications for use of non-selective beta blockers, namely carvedilol, in compensated cirrhosis

    3. Review updates in management of clinically significant portal hypertension, including variceal bleeding, SBP prophylaxis, and hepatorenal syndrome

  • Renee Dversdal, MD, FACP, FAIUM

    Academia and Industry: Lessons from Both Sides of the Divide

    Learning Objectives: 

    1. Describe skills and lessons that translate directly from medicine to industry and vice versa.

    2. Recognize opportunities for clinician engagement with industry that align with academic values.

    3. Assess the benefits and risks of academic–industry collaboration.

  • Tessa Smith, DO

    Think Beyond Routine Cultures: Rare Prosthetic Joint Infection After BCG Immunotherapy

    Learning Objectives: 

    1. Identify complications of BCG immunotherapy

    2. Discuss challenges in diagnosing Mycobacterium bovis prosthetic joint infection

    3. Understand how presentation differs from a "classic" prosthetic joint infection

     

    Madeleine Gertz, DO

    A Case of Adult-Onset Still's Disease Masquerading as Dermatomyositis

    Learning Objectives: 

    1. Recognize that adult-onset Still’s disease can mimic dermatomyositis
    2. Understand that adult-onset Still’s disease remains a diagnosis of exclusion
    3. Identify that atypical persistent cutaneous findings may signal more severe disease

     

    Alex Belzer, MD

    Patient-Elected Code Status at Academic and Community Medical Centers

    Learning Objectives: 

    1. Understand the prevalence of various code statuses
    2. Consider factors that influence patient-elected code status
    3. Generate hypotheses to explain patterns in code status selection

     

    Quinn M. Nelson, MD, MPhil

    Hemolysis as an Independent Predictor of Acute Kidney Injury in Critically Ill Patients on Mechanical Circulatory Support: A Dose-Dependent Association with Plasma Free Hemoglobin

    Learning Objectives: 

    1. Recognize hemolysis as an independent risk factor for AKI in critically ill patients on mechanical circulatory support
    2. Understand that higher plasma free hemoglobin levels confer progressively greater AKI risk
    3. Apply these findings to clinical monitoring and risk stratification in patients on mechanical circulatory support

     

     

     

  • Ashly Albright, MD, MS; Nathanial Earp, MD; Pristine Mei, MD; Ravneet Waraich, MD, MAB

    Positive Leadership: Community Building Through Change

    Learning Objectives: 

    1. Review the history of the literature of moral injury/belonging in medicine

    2. Apply belonging/authentic leadership to chief residents

    3. Introduce our interventions from this past year

    4. Designing our study to evaluate our interventions

     

  • Caleb Schmid, MD; Doug Rice, MD; Jennifer Kime, CNS

    Subcutaneous Insulin Pathway for Management of Mild-to-Moderate Diabetic Ketoacidosis at the Portland VA Medical Center

    Learning Objectives: 

    1. Understand evidence supporting subcutaneous insulin for management of mild to moderate diabetic ketoacidosis (DKA).

    2. Identify and appreciate challenges to improving patient safety in DKA management.

    3. Apply lessons learned to local settings and guide iterative improvements.

     

  • Adel Kardosh MD, PhD

    The Next Frontier in Pancreatic Cancer Treatment

    Learning Objectives: 

    1. Understand the difficulty of pancreatic cancer treatment

    2. KRAS inhibitors; the new generation of targetable agents

    3. New treatment approval for pancreatic cancer

     

    Brett C. Sheppard MD, FACS

    Pancreatic cancer, Beyond the blade

    Learning Objectives:

    1. Understand the risk factors for pancreatic adenocarcinoma and the rising incidence globally and in the U.S.
    2. Understand the role of pancreatic cancer high-risk surveillance clinic and the opportunity for disease interception.
    3. Understand the impact of allostatic load on the inception and therapy of pancreatic adenocarcinoma.

  • Kamini Kuchinad, MD

    Building Trust Through Communication: Improving Care for Individuals with Medically Unexplained Symptoms

    Learning Objectives: 

    1. Describe the clinical and health system impacts of medically unexplained symptoms

    2. Explore barriers and facilitators to effective communication in the care of individuals with medically unexplained symptoms

    3. Identify evidence-based strategies to improve the care for this vulnerable population

  • Bart Moulton, MD, FCCP

    The Oregon Trail for Rural Health Education

    Learning Objectives: 

    1. Understand the current state of rural health education.

    2. Identify challenges that rural health students face.

    3. Explain what OHSU is doing to improve rural health education across the university.

  • Jonathan Q. Purnell, MD

    The Future of Preventing Cardiovascular Disease

    Learning Objectives: 

    1. To understand the importance of non-HDL cholesterol (TG) reduction in CAD risk management.

    2. To understand how adiposity contributes to CAD risk, and how weight management improves MACE outcomes.

    3. To understand how advanced non-invasive imaging techniques can assist with treat-to-target determinations in CV risk management.

  • Cyanndi Dove, DPM

    The Diabetic Foot as a System Failure- From Reactive Wound Care to Proactive Limb Preservation

    Learning Objectives: 

    1. Recognize at least 4 elements of systemic failures, it pertains to the diabetic foot.

    2. Recognize the importance of utilizing a multidisciplinary limb preservation team to reduce atraumatic limb amputations.

    3. Name of recommended frequency diabetic foot examinations as per the ADA and the International Working Group- Diabetic Foot.

  • Jessica Bahena Lopez, MD, PhD

    Hypercalcemia and the Calcium-Sensing Receptor: New Insights and Renal Perspectives

    Learning Objectives: 

    1. Explain calcium homeostasis and its alterations during hypercalcemia.

    2. Describe how extracellular calcium is sensed and how the CaSR serves as a therapeutic target.

    3. Describe how the kidney regulates calcium balance and discuss new insights into renal calcium cell specialization.

  • Are you...?*

  • How did you view today's presentation*
  • Rows
  • Did this presentation achieve the stated objectives?
  • Did you learn new information and strategies that you can apply to your work or practice?
  • Was the information/material presented at this CME activity free from commercial bias? Yes NoIf no, please explain:
  • Are you a Physician?*

  • By providing your licensing state, license number and date of birth, you are granting OHSU Continuing Professional Development permission to upload your CME credit to the ACCME. This information will only be used to upload CME credits to the ACCME reporting system. Providing the information will decrease the administrative burden of CME reporting, enabling you to spend less time tracking and uploading CME credits and dedicate more of your time to high-quality learning.

     

  • Are you a board certified physician and want MOC Part II points for this session?*

  • ABMS member boards require an assessment in order to award MOC Part II points.

    Instructions for earning MOC points for this course

    You will be asked to provide a short (25 word minimum) reflection of what you learned at this session. The reflection should take the form of a clinical pearl from the talk that you will take back to your practice or share with a colleague. This reflection is separate from the speaker evaluation and should refer to your learning, rather than the content or quality of the talk. The reflections will be anonymized and shared with other participants.

     

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
     

  • 0/0
  • Should be Empty: